David Del Valle
About David Del Valle
David Del Valle is a Senior Scientist at Bristol Myers Squibb in New Jersey, with extensive experience in organic and medicinal chemistry. He has held various research positions and contributed significantly to advancements in drug development.
Current Role at Bristol Myers Squibb
David Del Valle is currently serving as a Senior Scientist at Bristol Myers Squibb in New Jersey, United States. In this role, he leads research initiatives and mentors junior scientists and interns. He focuses on the synthesis of novel compounds for cancer treatment. His work has led to at least one patent application, emphasizing his significant contributions to the field of medicinal chemistry.
Previous Experience at Celgene and AkzoNobel
Before joining Bristol Myers Squibb, David Del Valle worked at Celgene as Scientist I from 2017 to 2019 in Summit, NJ. He also had roles at AkzoNobel, where he served as a Senior Research Chemist for 10 months in 2016 and as a Research Chemist from 2013 to 2016 in Brewster, NY. During his time at AkzoNobel, David contributed to various research projects and gained extensive experience in chemical research and development.
Academic Background and Achievements
David Del Valle earned his Ph.D. in Organic Chemistry from The University of Texas at Austin, where he studied from 2008 to 2013. He also holds an M.A. in Chemistry and a B.S. in Medicinal Chemistry from the University at Buffalo. His doctoral research earned him the 'Outstanding Researcher Award' for exceptional contributions to organic chemistry. He has authored several research papers and presented his work at the American Chemical Society (ACS) national meetings, highlighting his innovative research in drug development.
Collaborative Research and Cross-Industry Innovation
David Del Valle has participated in collaborative research projects with leading pharmaceutical companies, enhancing cross-industry innovation. His work has led to significant advancements in medicinal chemistry and drug development. Through these collaborations, he has been able to share knowledge and drive research initiatives that push the boundaries of current scientific understanding.